Study finds Monteloeder's Metabolaid supports weight loss goals and emotional stability

Published: 10-Dec-2025

The lemon verbena-hibiscus blend helped participants with cravings, emotional eating, eating habits and motivation during an eight-week period

Results from a recent consumer study reveal Metabolaid, a botanical blend formulated by Monteloeder, helps consumers take better control of their weight and stay on track.

The proprietary botanical blend combines standardised extracts from hibiscus (Hibiscus sabdariffa) and lemon verbena (Lippia citrodora) designed to work together to help regulate appetite and support optimum metabolic function.


The US-based consumer study drew the opinions of 112 adult participants who took a 500 mg daily dose of the botanical supplement for a period of eight weeks.

They also completed a self-assessment questionnaire at the end of each week to document their progress.


The results indicated that Metabolaid had a positive impact on participants’ weight management journey and on how motivated and emotionally balanced they felt throughout the programme.

On a physical level, participants showed an overall weight reduction of around three-per-cent by the end of the eight-week assessment.

The weight changed in a slow-but-sustained downward trajectory. Improvements began to show already in the first week and continued through to week eight.

Four weeks into the assessment, participants reported noticeable increases in motivation and energy.

Motivation to maintain healthier routines endured throughout the evaluation. Participants also reported fewer urges to snack due to boredom, stress, or sadness, indicating greater control of their emotional eating.  

They also expressed a sense of genuine progress and greater satisfaction with the protocol.

Less emotional eating, more motivation

Users noted improvements in their overall mindset, which is often associated with healthier eating habits and better weight management.

They reported having fewer food cravings and fewer hunger pangs between meals.

More than 70% of participants felt that their eating habits had improved.

This was characterised by experiencing greater control of snacking and an increased preference for healthier options, especially from the fourth week onwards.

The weight loss was accompanied by a notable decrease in feelings of bloating, as reported by about one-third of participants.

Daily supplementation with Metabolaid also seemed to trigger the desire to engage in more active, health-forward daily routines.

Around two-thirds of users expressed feeling more energised and, after four weeks, reported they were exercising more, engaging in sport or physical activity at least three times per week. 

"A common complaint is that healthy eating routines are challenging to maintain," said Mariana Ortega-Rufino, Science Marketing Manager for SUANNUTRA.

"Motivation often fades after the first weeks. Restrictive diets often backfire due to low energy, strong cravings and increased stress, all of which make consistency difficult."

"This consumer study not only helped us better understand how people progress along their wellness journey but also highlighted how Metabolaid may inspire long-term adherence."

"Metabolaid seems to offer its users an emotional lift which keeps their motivation strong in addition to its physical effects.”

Staying on track

Metabolaid is backed by ten preclinical and clinical studies that included more than 450 volunteers, each study demonstrating its supportive role in areas related to weight control.

Previous studies demonstrated that it may influence pathways associated with metabolism, including adenosine monophosphate-activated protein kinase (AMPK), which is known to be involved in energy balance and satiety.

It has also been shown to support a balanced gut microbiome owing to its prebiotic properties.

Two months of supplementation with the polyphenol-rich botanical composition has also been linked to more optimal GLP-1 levels, the gut hormone that has been receiving abundant attention lately.


GLP-1 is a natural hormone produced in the body (usually after eating) that helps control blood sugar by instructing the pancreas to release insulin and controls appetite by slowing down digestion and sending fullness signals to the brain.


"Following a string of clinical trials that uncovered the science behind Metabolaid’s wellness benefits, we felt a consumer study would provide insights into the consumers' perceptions of the product," said Dr Jonathan Jones, Chief R&D Officer for Monteloeder.

"From their feedback, we discovered Metabolaid’s potential to support individuals along their weight-management journey by addressing both physical and emotional factors."

"It seems to be associated with fewer self-reported episodes of emotional eating, while empowering users to make better lifestyle decisions, embrace healthier routines and feel more positive about their daily eating patterns."

"These self-perceived shifts may contribute to behaviours that support long-term weight-management efforts.”

You may also like